{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"5","upperLimit":"35","value":"14.5"},{"groupId":"OG001","lowerLimit":"7","upperLimit":"181","value":"15.5"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"14"}],"units":"Participants"}],"dispersionType":"95% Confidence Interval","groups":[{"description":"Adult oncology patients who have been treated for ≥ 1 episode of hyponatraemia secondary to the SIADH according to the SEOM algorithm and who were candidate for or actually in chemotherapy treatement when the hyponatremia episode occurred.","id":"OG000","title":"Subjects With Chemotherapy Treated as Per SEOM Algorithm"},{"description":"Adult oncology patients who have been treated for ≥ 1 episode of hyponatraemia secondary to the SIADH NOT according to the SEOM algorithm and who were candidate for or actually in chemotherapy treatement when the hyponatremia episode occurred","id":"OG001","title":"Subjects With Chemotherapy NOT Treated as Per SEOM Algorithm"}],"paramType":"MEDIAN","populationDescription":"In this analysis, only the 22 patients who were candidate for chemotherapy during the study period were included, this explains the difference with the total number of participants.","reportingStatus":"POSTED","timeFrame":"Longitudinal (up to discharge or a maximum of 6 weeks after onset of hyponatremia episode)","title":"Time to Initiation or Re-initiation of Chemotherapy (Since the Start of the Hyponatraemia Episode) in Patients Candidate for Chemotherapy Who Were and Were Not Treated in Adherence With the SEOM Algorithm.","type":"SECONDARY","unitOfMeasure":"Hours"}